Source:http://linkedlifedata.com/resource/pubmed/id/16772331
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2006-10-5
|
| pubmed:abstractText |
Bioactive retinoids are potent limb teratogens, upregulating apoptosis, decreasing chondrogenesis, and producing limb-reduction defects. To target the origins of these effects, we examined gene expression changes in the developing murine limb after 3 h of culture with teratogenic concentrations of vitamin A. Embryonic day 12 CD-1 limbs were cultured in the absence or presence of vitamin A (retinol acetate) at 1.25 and 62.5muM (n = 5). Total RNA was used to probe Atlas 1.2 cDNA arrays. Eighty-one genes were significantly upregulated by retinol exposure; among these were key limb development signaling molecules, extracellular matrix and adhesion proteins, oncogenes, and a large number of transcriptional regulators, including Eya2, Id3, Snail, and Hes1. To relate these expression changes to teratogenic outcome, the response of these four genes was assessed after culture with vitamin A and retinoid receptor antagonists that are able to rescue retinoid-induced malformations; expression levels were correlated with limb malformations. Lastly, pathways analysis revealed that a large number of the genes significantly affected by retinoid treatment are functionally linked through direct interactions. Several regulatory gene cascades emerged relevant to morphogenesis, cell-fate, and chondrogenesis; moreover, members of these cascades crosstalk with one other. These results indicate that retinoids act in a coordinated fashion to disrupt development at multiple levels. In sum, this work proposes several unifying mechanisms for retinoid-induced limb malformations, identifies novel retinoid targets, and highlights Eya2, Id3, Snail, and Hes1 as potential key teratogenic effectors.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
1096-6080
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
94
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
139-52
|
| pubmed:dateRevised |
2010-9-17
|
| pubmed:meshHeading |
pubmed-meshheading:16772331-Animals,
pubmed-meshheading:16772331-Apoptosis,
pubmed-meshheading:16772331-Cell Differentiation,
pubmed-meshheading:16772331-Cluster Analysis,
pubmed-meshheading:16772331-Dose-Response Relationship, Drug,
pubmed-meshheading:16772331-Down-Regulation,
pubmed-meshheading:16772331-Forelimb,
pubmed-meshheading:16772331-Gene Expression Profiling,
pubmed-meshheading:16772331-Gene Expression Regulation, Developmental,
pubmed-meshheading:16772331-Mice,
pubmed-meshheading:16772331-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:16772331-Organogenesis,
pubmed-meshheading:16772331-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16772331-Signal Transduction,
pubmed-meshheading:16772331-Teratogens,
pubmed-meshheading:16772331-Time Factors,
pubmed-meshheading:16772331-Tissue Culture Techniques,
pubmed-meshheading:16772331-Up-Regulation,
pubmed-meshheading:16772331-Vitamin A
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
Novel retinoid targets in the mouse limb during organogenesis.
|
| pubmed:affiliation |
Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada H3G 1Y6.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|